WDC Biotech Fund I, LLC
Raised
$450K
Investors
17
Min Invest
$25,000
AltStreet Analysis
·Generated from EDGAR primary sources
WDC Biotech Fund I, LLC is a Delaware pooled investment fund focused on longevity biotech, filed by Woodward Diversified Capital LLC and affiliated directors Gabriel, Beau, and Thomas Woodward. This amended filing reports $450K raised from 17 investors under Rule 506(b) and 3(c)(1) exemptions, with a $25K minimum investment. No first sale date is disclosed.
Within the longevity biotech category, this fund employs a 506(b) private placement structure with a relatively accessible $25K minimum investment threshold, lower than many institutional biotech vehicles. The 3(c)(1) exemption limits the fund to 100 beneficial owners, typical for private venture funds in emerging biotech sectors.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
n/a Woodward Diversified Capital LLC
Director · Bakerfield, CA
Gabriel Woodward
Director · Bakersfield, CA
Beau Woodward
Director · Bakersfield, CA
Thomas Woodward
Director · Bakersfield, CA
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
